Literature DB >> 1998641

Cholesterol accumulation in J774 macrophages induced by triglyceride-rich lipoproteins. Comparison of very low density lipoprotein from subjects with type III, IV, and V hyperlipoproteinemias.

M W Huff1, A J Evans, C G Sawyez, B M Wolfe, P J Nestel.   

Abstract

The capacity of human triglyceride-rich lipoproteins to induce cholesterol accumulation in the murine J774 macrophage cell line was investigated with large very low density lipoprotein (VLDL, Sf 60-400) obtained from subjects with type III, IV, and V hyperlipoproteinemias. After incubation for 24 hours, VLDLs from type IV and type V subjects were similar in their ability to raise cellular cholesterol deposition threefold to fourfold and cellular triglyceride 16-fold. The increase in cholesterol was entirely due to the dramatic increase in cholesterol ester, from less than 1 to greater than 50 micrograms/mg cell protein. Total cholesterol accumulation was fourfold to fivefold greater than the cholesterol accumulation observed for VLDL or low density lipoprotein (LDL) from normal subjects. Cholesterol esterification (acyl coenzyme A: cholesterol acyltransferase [ACAT] activity) paralleled the rate of cholesterol accumulation in these cells. Treating the macrophages with the ACAT inhibitor 58035, which is known to downregulate the LDL receptor in these cells, diminished cholesterol accumulation by 40% for type IV VLDL and by 23% for normal LDL. Since hypertriglyceridemic VLDL carries excess apoprotein (apo) E molecules, we investigated the role of normal and abnormal apo E. An anti-apo E monoclonal antibody, known to block the binding of apo E to the LDL receptor, blocked type IV VLDL-induced cholesterol ester accumulation by approximately 70%. In contrast to type IV subjects, VLDL from type III subjects (homozygous for apo E2) when incubated with J774 macrophages (which do not secrete apo E) caused only a modest 1.5-2-fold increase in cellular cholesterol. Pre-beta- and beta-migrating VLDL subfractions from type III subjects were equally ineffective in causing cholesterol accumulation. By contrast, beta-VLDL from cholesterol-fed rabbits caused a sevenfold to eightfold increase in cellular cholesterol content. These results indicate that triglyceride-rich lipoproteins from type IV and type V subjects can cause substantial cholesterol ester accumulation and enhanced cholesterol esterification in J774 cells. The lower cholesterol accumulation with type IV VLDL in the presence of apo E antibodies and VLDL from type III subjects demonstrates the importance of functional apo E in this process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1998641     DOI: 10.1161/01.atv.11.2.221

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  10 in total

1.  Macrophage adipose triglyceride lipase deficiency attenuates atherosclerotic lesion development in low-density lipoprotein receptor knockout mice.

Authors:  Bart Lammers; Prakash G Chandak; Elma Aflaki; Gijs H M Van Puijvelde; Branislav Radovic; Reeni B Hildebrand; Illiana Meurs; Ruud Out; Johan Kuiper; Theo J C Van Berkel; Dagmar Kolb; Guenter Haemmerle; Rudolf Zechner; Sanja Levak-Frank; Miranda Van Eck; Dagmar Kratky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-10-28       Impact factor: 8.311

2.  Increased susceptibility to peroxidation of VLDL from non-insulin-dependent diabetic patients: a possible correlation with fatty acid composition.

Authors:  R A Rabini; M Tesei; T Galeazzi; N Dousset; G Ferretti; L Mazzanti
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

3.  Lipoprotein lipase regulates Fc receptor-mediated phagocytosis by macrophages maintained in glucose-deficient medium.

Authors:  B Yin; J D Loike; Y Kako; P H Weinstock; J L Breslow; S C Silverstein; I J Goldberg
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

4.  Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations.

Authors:  E Boerwinkle; S Brown; A R Sharrett; G Heiss; W Patsch
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

5.  Efficient phagocytosis requires triacylglycerol hydrolysis by adipose triglyceride lipase.

Authors:  Prakash G Chandak; Branislav Radovic; Elma Aflaki; Dagmar Kolb; Marlene Buchebner; Eleonore Fröhlich; Christoph Magnes; Frank Sinner; Guenter Haemmerle; Rudolf Zechner; Ira Tabas; Sanja Levak-Frank; Dagmar Kratky
Journal:  J Biol Chem       Date:  2010-04-27       Impact factor: 5.157

Review 6.  Pharmacological control of hypertriglyceridemia.

Authors:  G Franceschini; R Paoletti
Journal:  Cardiovasc Drugs Ther       Date:  1993-06       Impact factor: 3.727

7.  Unavailability of liver triacylglycerol increases serum cholesterol concentration induced by dietary cholesterol in exogenously hypercholesterolemic (ExHC) rats.

Authors:  Yasutake Tanaka; Koji Nagao; Hideaki Nakagiri; Toshirou Nagaso; Yasue Iwasa; Haruhiko Mori; Makoto Asahina; Katsumi Imaizumi; Masao Sato
Journal:  Lipids Health Dis       Date:  2014-01-22       Impact factor: 3.876

8.  Non-high-density lipoprotein cholesterol predicts nonfatal recurrent myocardial infarction in patients with ST segment elevation myocardial infarction.

Authors:  Ming Gao; Yang Zheng; Weihua Zhang; Yi Cheng; Lin Wang; Ling Qin
Journal:  Lipids Health Dis       Date:  2017-01-23       Impact factor: 3.876

9.  The oxysterol 24(s),25-epoxycholesterol attenuates human smooth muscle-derived foam cell formation via reduced low-density lipoprotein uptake and enhanced cholesterol efflux.

Authors:  Michael M Beyea; Samantha Reaume; Cynthia G Sawyez; Jane Y Edwards; Caroline O'Neil; Robert A Hegele; J Geoffrey Pickering; Murray W Huff
Journal:  J Am Heart Assoc       Date:  2012-06-22       Impact factor: 5.501

10.  Lipoprotein markers associated with disability from multiple sclerosis.

Authors:  A R Gafson; T Thorne; C I J McKechnie; B Jimenez; R Nicholas; P M Matthews
Journal:  Sci Rep       Date:  2018-11-19       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.